CA125 suppresses amatuximab immune-effector function and elevated serum levels are associated with reduced clinical response in first line mesothelioma patients.
about
CA125 suppresses amatuximab immune-effector function and elevated serum levels are associated with reduced clinical response in first line mesothelioma patients.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
CA125 suppresses amatuximab im ...... st line mesothelioma patients.
@en
CA125 suppresses amatuximab im ...... st line mesothelioma patients.
@nl
type
label
CA125 suppresses amatuximab im ...... st line mesothelioma patients.
@en
CA125 suppresses amatuximab im ...... st line mesothelioma patients.
@nl
prefLabel
CA125 suppresses amatuximab im ...... st line mesothelioma patients.
@en
CA125 suppresses amatuximab im ...... st line mesothelioma patients.
@nl
P2093
P2860
P1476
CA125 suppresses amatuximab im ...... st line mesothelioma patients.
@en
P2093
Charles Schweizer
Elizabeth B Somers
Erin N Ross
J Bradford Kline
Luigi Grasso
Nicholas C Nicolaides
Raffit Hassan
Shawn Fernando
Wenquan Wang
P2860
P304
P356
10.1080/15384047.2018.1449614
P577
2018-04-25T00:00:00Z